Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ginkgo Bioworks Holdings Inc shares valued at $676 were purchased by Che Austin on May 07 ’25. At $6.83 per share, Che Austin acquired 99 shares.
Also, Che Austin purchased 99 shares, netting a total of over 668 in proceeds.
Before that, Che Austin had added 99 shares to its account. In a trade valued at $693, the Officer bought Ginkgo Bioworks Holdings Inc shares for $7.00 each.
As published in a research note from BTIG Research on May 15, 2024, Ginkgo Bioworks Holdings Inc [DNA] has been rated down from a Neutral to a Sell. Analysts at William Blair downgraded the stock from ‘”a Mkt perform”‘ to ‘”an Underperform”‘ outlook in a report released in early May. As of November 14, 2023, Raymond James has decreased its “an Outperform” rating to a “Mkt perform” for DNA. Earlier on November 09, 2023, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for DNA stock which previously was a “a Buy”.
Analyzing DNA Stock Performance
During the last five days, there has been a surge of approximately 0.41%. Over the course of the year, Ginkgo Bioworks Holdings Inc shares have dropped approximately -24.64%. Shares of the company reached a 52-week high of $16.85 on 02/06/25 and a 52-week low of $5.00 on 04/04/25. A 50-day SMA is recorded $7.24, while a 200-day SMA reached $9.03.
Support And Resistance Levels for Ginkgo Bioworks Holdings Inc (DNA)
According to the 24-hour chart, there is a support level at 6.74, which, if violated, would cause prices to drop to 6.09. In the upper region, resistance lies at 7.82. The next price resistance is at 8.25. RSI (Relative Strength Index) is 50.49 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.48, which suggests the price will decrease in the coming days. Percent R is at 52.20%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
